Lebwohl David Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
9
Insider Sells Sum
$2.26M

Insider Activity of Lebwohl David

According to the SEC Form 4 filings, Lebwohl David, being in a position of

  1. EVP, Chief Medical Officer at Intellia Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 11903 shares for $109,627,
    over all time since 2021-08-09, has bought 0 shares, and sold 42928 shares for $2.37M.

Biography of Lebwohl David

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $109,6271100

Comparison of Insiders on Amount of Buys and Sells

2026-01-05SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Medical Officer
11,903
0.0112%
$9.21$109,627+36.93%
2025-01-03SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Medical Officer
9,557
0.0094%
$12.18$116,404-19.95%
2024-01-03SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Medical Officer
5,843
0.0065%
$29.46$172,135-22.09%
2023-01-04SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Medical Officer
2,574
0.0028%
$37.21$95,779-3.42%
2022-01-01SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Medical Officer
1,051
0.0013%
$112.24$117,964-50.72%
2021-11-05SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Medical Officer
2,400
0.0033%
$132.72$318,535-53.13%
2021-10-14SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Medical Officer
2,400
0.0033%
$128.44$308,249-50.27%
2021-09-21SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Medical Officer
2,400
0.0033%
$149.81$359,544-52.58%
2021-08-30SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Medical Officer
2,400
0.0033%
$158.04$379,300-48.07%
2021-08-09SaleIntellia Therapeutics, Inc.
NTLA
EVP, Chief Medical Officer
2,400
0.0033%
$164.05$393,720-43.95%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.